Shu Chen

Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma

T. Zhu, P. Lobie, V. Pandey, 2022, Cell Death & Disease.

Combined inhibition of BADSer99 phosphorylation and PARP ablates models of recurrent ovarian carcinoma

T. Zhu, P. Lobie, V. Pandey, 2022, Communications Medicine.

The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology

Xiaoyang Zhang, L. Mei, Li Mu, 2023, Frontiers in Pharmacology.

Venlafaxine, an anti-depressant drug, induces apoptosis in MV3 human melanoma cells through JNK1/2-Nur77 signaling pathway

Ting Niu, Ruihe Zheng, Shu Chen, 2023, Frontiers in Pharmacology.

Inhibition of brain protein kinase C subtypes by lead.

K. Murakami, Shu Chen, G. Feng, 1993, The Journal of pharmacology and experimental therapeutics.

Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer

P. Lobie, Xi Zhang, Shu Chen, 2024, Translational oncology.